Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

What symbol and exchange does Kenvue shares trade?

Kenvue trades on the NYSE stock market under the symbol KVUE.

What is Kenvue stock price doing today?

As of October 26, 2026, KVUE stock price declined to $19.50 with 7,121,176 million shares trading.

What is Kenvue's Beta?

KVUE has a beta of -0.32, meaning it tends to be less sensitive to market movements. KVUE has a correlation of 0.02 to the broad based SPY ETF.

How much is Kenvue worth?

KVUE has a market cap of $37.44 billion. This is considered a Large Cap stock.

How much money does Kenvue make?

Last quarter Kenvue reported $4 billion in Revenue and $.31 earnings per share. This fell short of revenue expectation by $-17 million and missed earnings estimates by -$.01.

What is the highest and lowest price Kenvue traded in the last 3 year period?

In the last 3 years, KVUE traded as high as $25.17 and as low as $14.02.

What are the top ETFs holding Kenvue?

The top ETF exchange traded funds that KVUE belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.

Is Kenvue (KVUE) a good investment?

KVUE has outperformed the market in the last year with a price return of +37.0% while the SPY ETF gained +14.1%. However, in the short term, KVUE had mixed performance relative to the market. It has underperformed in the last 3 months, returning +3.3% vs +3.8% return in SPY. But in the last 2 weeks, KVUE shares have fared better than the market returning +9.4% compared to SPY -1.6%.

What are the support and resistance levels for Kenvue (KVUE)?

KVUE support price is $19.29 and resistance is $19.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KVUE shares will trade within this expected range on the day.